Related Experiment Video
Updated: Jun 23, 2026
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
New perspectives for synergy research with the "omic"-technologies
G Ulrich-Merzenich1, D Panek, H Zeitler
1Medical Policlinic of the Rheinische Friedrich-Wilhelms-University of Bonn, Wilhelmstr. 35-37, D-53111 Bonn, Germany. gudrun.ulrich-merzenich@ukb.uni-bonn.de
Summary
Phytopharmaceuticals exhibit synergistic effects, enhancing drug efficacy and safety. "Omic"-technologies enable rational development of these herbal medicines and combination therapies for multifactorial diseases.
Area of Science:
- Pharmacology and Herbal Medicine
- Systems Biology
- Drug Development
Background:
- Synergistic effects, or overadditive interactions, are frequently observed with phytopharmaceuticals in research and clinical settings.
- The advent of "omic"-technologies offers novel approaches to understand and leverage these synergistic effects for advanced phytopharmaceutical development.
Purpose of the Study:
- To review mechanisms of synergistic action in herbal medicines, including mono- and multitargeting and signal cascade activation.
- To explore the application of "omic"-technologies for standardizing plant extracts, assessing toxicity, and enabling personalized medicine approaches.
- To propose strategies for integrating "omic"-technologies in developing combination therapies of phytopharmaceuticals and synthetic drugs to optimize efficacy and minimize adverse reactions.
Main Methods:
- Literature review of synergistic mechanisms in phytopharmaceuticals.
- Analysis of "omic"-technologies (genomics, proteomics, metabolomics) for standardization, safety assessment, and drug development.
- Examination of clinical studies on combination therapies involving phytopharmaceuticals.
Main Results:
- Synergistic effects in phytopharmaceuticals can be achieved through various mechanisms, including multitargeting and signal pathway modulation.
- "Omic"-technologies provide tools for rationalizing phytopharmaceutical development, standardization, and safety evaluation.
- Combination therapies with phytopharmaceuticals and synthetic drugs show potential for improved therapeutic outcomes and reduced adverse reactions.
Conclusions:
- "Omic"-technologies are crucial for understanding and exploiting synergistic effects of phytopharmaceuticals.
- Systematic application of synergy principles can lead to evidence-based phytomedicinal interventions for multifactorial diseases.
- Integrating phytopharmaceuticals into combination therapies can enrich modern pharmacotherapy with safer and more effective options.
Related Concept Videos
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...